MILWAUKEE and SALT LAKE CITY (August 21) — Today, Blackrock NeuroMed LLC and the Children’s Hospital of Wisconsin announced a clinical affiliation that will advance the treatment of childhood epilepsy and provide insight into other neurodegenerative diseases.

At the heart of the clinical affiliation is Blackrock NeuroMed’s Cervello System, which allows doctors to examine patients’ electrical brain activity at previously impossible levels of accuracy.

“Cervello dramatically improves our ability to treat epilepsy patients,” said Dr. Kurt Hecox, a pediatric neurologist at Children’s. “The system gives us a much clearer look at the electrical signals in patients’ brains. As a result, we can identify the precise region in the brain where a patient’s seizures are originating — and have it removed quickly and accurately.”

The Cervello System incorporates three primary technologies: an electroencephalogram, a high-definition video camera, and a sophisticated data-recording device that can monitor the brain’s electrical activity.

Children’s 25 Cervello units are housed in their pediatric epilepsy center, the highest-ranked such center in Wisconsin. Cervello is empowering researchers at Children’s to examine brain activity at the level of an individual neuron. That represents a significant improvement over the imprecise hundred- and thousand-neuron views offered by other EEG technology.

For the more than 300,000 American children with epilepsy, the treatment Cervello enables could be revolutionary.”Cervello is the new gold standard for EEG technology,” said Andy Gotshalk, CEO of Blackrock NeuroMed. “The system fuels cutting-edge epilepsy treatments that would have seemed like science fiction just a few years ago.”We hope that Cervello will empower researchers to better understand neurodegenerative disorders like depression, Alzheimer’s, and Parkinson’s — and eventually, to treat or even cure them.”

For additional info:


Comments are closed.